Brookline, MA, United States of America

Martin Beinborn


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1998-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Martin Beinborn: Innovator in Peptide Hormone Receptor Agonists

Introduction

Martin Beinborn is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of biochemistry, particularly in the area of peptide hormone receptor agonists. With a total of three patents to his name, Beinborn's work has the potential to impact the treatment of various physiological diseases.

Latest Patents

Beinborn's latest patents focus on methods for determining whether a candidate compound is a non-peptide agonist of a peptide hormone receptor. The first patent describes a method where a candidate compound is exposed to a form of the peptide hormone receptor that enhances the intrinsic activity of non-peptide agonists. By measuring the second messenger signaling activity of the enhanced receptor in the presence of the candidate compound, researchers can determine if the compound acts as an agonist. An increase in signaling activity indicates a full or partial positive agonist, while a decrease suggests an inverse agonist. The second patent mirrors this approach, emphasizing the importance of the enhanced receptor in identifying non-peptide agonists.

Career Highlights

Throughout his career, Martin Beinborn has worked with reputable organizations, including New England Medical Center Hospitals, Inc. and New England Medical Center. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

One of his notable collaborators is Alan S. Kopin, with whom he has worked on various projects related to peptide hormone receptors. Their combined expertise has further advanced the understanding of receptor mechanisms and potential therapeutic applications.

Conclusion

Martin Beinborn's innovative work in the realm of peptide hormone receptor agonists showcases his dedication to advancing medical science. His patents not only highlight his inventive spirit but also pave the way for future research and development in treating physiological diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…